Science Explorer Interactive view Map
Hospital / health system · Wilmington · United States

Carolina Arthritis Associates

Research works
31
▼ 25% vs 2013–17
Citations
968
31.6 per fractional work
Top-10% rate
11.7%
record average 16.5%
Open access
32%
world 28%

Not ranked overall: Carolina Arthritis Associates is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Carolina Arthritis Associates?

By fractional works in all years, weighted toward what it does more of than the world: Autoantibodies, Inflammation, Cardiovascular Risk, Epidemiology, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Treatment and Cytokines.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Autoantibodies7▲ 91×5 topics
  2. Inflammation5▲ 7.5×13 topics
  3. Epidemiology5▲ 3.8×18 topics
  4. Cardiovascular Risk4▲ 33×3 topics
  5. Antiphospholipid Syndrome3▲ 210×1 topic
  6. Systemic Lupus Erythematosus3▲ 192×1 topic
  7. Treatment3▲ 7.7×9 topics
  8. Biological Therapy3▲ 156×1 topic
  9. Cytokines3▲ 33×2 topics
  10. Rheumatoid Arthritis3▲ 85×1 topic
  11. Monoclonal Antibodies2▲ 37×2 topics
  12. Juvenile Idiopathic Arthritis2▲ 99×2 topics
  13. Psychological Factors2▲ 26×2 topics
  14. Hemophagocytic Lymphohistiocytosis1▲ 213×1 topic
  15. Macrophage Activation Syndrome1▲ 213×1 topic
  16. Fc Receptors1▲ 42×1 topic
  17. Therapeutic Antibodies1▲ 33×1 topic
  18. Diagnosis1▲ 3.9×5 topics
  19. Chronic Fatigue Syndrome1▲ 142×1 topic
  20. Fibromyalgia1▲ 142×1 topic
  21. Muscle Damage1▲ 70×2 topics
  22. Pathophysiology1▲ 13×3 topics

Which research topics does Carolina Arthritis Associates publish most on?

By volume in 2022–2025: Systemic Lupus Erythematosus Research, Cardiovascular Disease and Adiposity, Rheumatoid Arthritis Research and Therapies and Fibromyalgia and Chronic Fatigue Syndrome Research.

  1. 1 Systemic Lupus Erythematosus Research Rheumatology 0 works
  2. 2 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 0 works
  3. 3 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  4. 4 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 0 works
  5. 5 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  6. 6 Autoimmune and Inflammatory Disorders Research Hematology 0 works
  7. 7 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
  8. 8 Peroxisome Proliferator-Activated Receptors Molecular Biology 0 works
  9. 9 Peripheral Neuropathies and Disorders Neurology 0 works
  10. 10 Herpesvirus Infections and Treatments Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.7%not open68.3%

World: 28% of research is openly available.

with international co-authors14.9%domestic only85.1%

World: 19% is written across borders.

How has Carolina Arthritis Associates's research output changed?

Output in 2018–2022 was 25% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Wilmington

All research institutions in Wilmington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.